Showing 121 - 140 results of 104,579 for search '(( 2 c decrease ) OR ( 5 ((((teer decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 1.87s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…A) Representative flow charts show gating strategy (left panel) based on size (Forward Scatter) and granularity (Side Scatter) of the cells, and (central and right panel) Carboxy-H<sub>2</sub>DCFDA signal. B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  11. 131
  12. 132
  13. 133

    Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

    Published 2015
    “…Cy5/Red, <i>C</i>. <i>parvum</i>; Cy3/green, SHP-2. …”
  14. 134

    Increased Dietary Intake of Saturated Fatty Acid Heptadecanoic Acid (C17:0) Associated with Decreasing Ferritin and Alleviated Metabolic Syndrome in Dolphins by Stephanie K. Venn-Watson (774138)

    Published 2015
    “…To assess potential protective factors against metabolic syndrome related to fish diets, fatty acids were compared between two dolphin populations with higher (n = 30, Group A) and lower (n = 19, Group B) mean insulin (11 ± 12 and 2 ± 5 μIU/ml, respectively; <i>P</i> < 0.0001) and their dietary fish. …”
  15. 135

    FUD transiently decreased IOP in mice injected with Ad5-TGFβ2 viral vector. by Jennifer A. Faralli (4907311)

    Published 2020
    “…FUD significantly decreased IOP on Day 17 (2 days after it was injected on Day 15; *p<0.05). n = 6, 15, 13 and 12 for TGFβ2 only, TGFβ2 + FUD, TGFβ2 + PBS and TGFβ2 + mFUD treated eyes respectively. …”
  16. 136
  17. 137

    POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

    Published 2015
    “…<b>(B)</b> POS treatment downregulated the Intracellular ROS levels evaluated by H<sub>2</sub>DCFDA. Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t</i>-test, **<i>P</i> < 0.01, ***<i>P</i> < 0.001; ns, not significant. …”
  18. 138
  19. 139
  20. 140